ProCE Banner Activity

Management of Patients with Newly Diagnosed CLL/SLL

Slideset

Download these slides from a live symposium at ASCO 2023 to gain more insights into the management of patients with newly diagnosed CLL/SLL

Released: June 02, 2023

Expiration: June 01, 2024

Share

Faculty

Farrukh T. Awan

Farrukh T. Awan, MD, MS, MBA

Associate Director, Section of Hematologic Malignancies/Transplantation and Cellular Therapy
Director of Lymphoid Malignancies Program
Harold C. Simmons Comprehensive Cancer Center
University of Texas Southwestern Medical Center
Dallas, Texas

Provided by

Provided by the National Comprehensive Cancer Network in collaboration with Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca, BeiGene Ltd, and Lilly. Supported by independent educational grants from Merck & Co., Inc., Rahway, NJ, USA, and Pharmacyclics, an AbbVie Company and Janssen Biotech, Inc.

AstraZeneca

BeiGene, Ltd.

Janssen Biotech, Inc.

Lilly

Merck Sharp & Dohme Corp.

Pharmacyclics LLC, an AbbVie Company

Partners

Clinical Care Options, LLC

ProCE Banner